Form 4: BP4 S.r.l. Sells MLSS Shares Under 10b5-1 Plan

BP4 S.r.l., a 10% owner and director of Milestone Scientific Inc., reported the sale of 40,000 common shares through a pre-arranged 10b5-1 trading plan.

Summary

• BP4 S.r.l., identified as a Director and 10% Owner of Milestone Scientific Inc. (MLSS), reported transactions involving the company's common stock.
• On October 7, 2025, BP4 S.r.l. disposed of 10,000 shares of common stock at a price of $0.45 per share.
• On October 8, 2025, an additional 30,000 shares of common stock were disposed of at a price of $0.465 per share.
• These transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following these transactions, BP4 S.r.l. beneficially owns 9,195,384 shares of Milestone Scientific Inc. common stock.

Sentiment

Score: 4

Explanation: While insider selling is generally a negative signal, the fact that these transactions were conducted under a pre-arranged 10b5-1 plan mitigates the immediate negative sentiment, suggesting a planned liquidity event rather than a reaction to adverse company news. However, it still represents a reduction in insider ownership.

Positives

• The transactions were conducted under a Rule 10b5-1 plan, indicating pre-scheduled sales rather than a reaction to recent negative company-specific news.

Negatives

• A significant insider, a 10% owner and director, has reduced their direct beneficial ownership by 40,000 shares, which can be perceived as a negative signal by investors.

Risks

• Insider selling, even if pre-planned, can sometimes be interpreted by the market as a lack of confidence in the company's near-term prospects, potentially leading to downward pressure on the stock price.

Future Outlook

NA

Management Comments

• The filing was signed by Dr. Pedro Palau, Liquidator, on behalf of BP4 S.r.l.

Industry Context

This filing is specific to an insider transaction and does not provide broader industry context or trends. Insider selling can occur for various personal liquidity reasons, irrespective of industry performance.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders may perceive the sale by a significant insider as a negative signal, potentially influencing investor confidence and the company's stock price.
• The pre-planned nature of the sale (10b5-1 plan) may temper concerns compared to an ad-hoc sale, but it still represents a reduction in a key insider's stake.

Next Steps

• NA

Key Dates

Recommendation

The sale of shares by a 10% owner and director is typically a negative indicator. However, the explicit mention that these transactions were executed under a Rule 10b5-1 plan suggests they are pre-scheduled and not necessarily a reaction to new, adverse information. This mitigates the immediate 'sell' signal, leading to a 'hold' recommendation as investors should monitor future developments rather than react solely to this pre-planned insider sale.

Keywords

Milestone Scientific, MLSS, BP4 S.r.l., Insider Selling, Form 4, 10b5-1 Plan, Common Stock, Director, 10% Owner